Similar articles

Abstract: Objective: To identify the mutations of iduronate-2-sulfatase (IDS) gene, to reveal its mutation features, and to establish a basis for genetic counseling and prenatal gene diagnosis of hunter syndrome. Methods: Urine glycosaminoglycans (GAGs) assay, PCR and DNA sequencing were performed to detect mutation of IDS gene of the patient and his parents. Results: The result showed that the patient was: DS(++), HS(++), KS(−), CS(−), and that both of his parents were negative. A frame-shift deletion mutation (1062 del 16) was identified in exon 7 of the patient’s IDS gene. His parents’ genotypes were normal. Conclusion: The patient’s mutation was not inherited by his parents but a novel one. The mutation probably altered the primary structure and tertiary structure of IDS enzyme protein remarkably and lowered the activity of IDS enzyme greatly. Therefore it is supposed to be the direct cause of the disorder.

[1] Alves, S., Mangas, M., Prata, M.J., Ribeiro, G., Lopes, L., Ribeiro, H., Pinto-Basto, J., Reis Lima, M., Lacerda, L., 2006. Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations. J. Inherit. Metab. Dis., 29(6):743-754.

[2] Dou, W., Peng, C., Zheng, J.K., Gu, X.F., 2007. Two new mutation of IDS gene from the patient with MPS II. Hereditas, 29(1):37-40 (in Chinese).

[3] Du, C.S., Liu, Z.D., 1992. Medical Genetics, 2nd Ed. People’s Healthy Press, Beijing, p.477 (in Chinese).

[4] Guo, Y.B., Du, C.S., 2006a. Detection of a new mutation (1343-TT) in the iduronate-2-sulfatase gene from a Chinese patient with mucopolysaccharidosis type II. Chin. J. Pediatr., 44(2):110-113 (in Chinese).

[5] Guo, Y.B., Du, C.S., 2006b. A new mutation (T1140C) from a Chinese Guangdong patient with Hunter syndrome. Hereditas, 28(5):521-524 (in Chinese).

[6] Guo, Y.B., Pan, J.X., Du, C.S., 2005. Detection of a new mutation (1467-A) for the pedigree with mucopolysaccharidosis type II from a Chinese family. Chin. Sci. Bull., 50(21):2534-2536.

[7] Guo, Y.B., Lin, Q.D., Du, C.S., 2006. A new mutation of iduronate-2-sulfatase gene from the patient with Hunter syndrome. Chin. J. Med. Genet., 23(1):67-69 (in Chinese).

[8] Hopwood, J.J., Bunge, S., Morris, C.P., Wilson, P.J., Steglich, C., Beck, M., Schwinger, E., Gal, A., 1993. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum. Mutat., 2(6):435-442.

[9] Huang, Y., Meng, Y.X., Guo, Y.B., 2007. The method of micro-dosage quick urinary GAGs assay. Sun Yat-sen University Forum, 27(3):179-181 (in Chinese).

[10] Liu, S.F., Li, L.Y., Fu, J.J., Zhong, C.G., Lu, G.X., 2002. The detection of the frequent mutations of iduronate-2-sulfatase gene in mucopolysaccharidosis type II patients in Chinese. Chin. J. Med. Genet., 19(3):243-245 (in Chinese).

[11] Lualdi, S., Pittis, M.G., Regis, S., Parini, R., Allegri, A.E., Furlan, F., Bembi, B., Filocamo, M., 2006. Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts. J. Mol. Med., 84(8):692-700.

[12] Luo, C.Q., 2000. The Progress of Gene Diagnosis and Gene Therapy, 1st Ed. Henan Medical University Press, Zhengzhou, p.91-92 (in Chinese).

[13] Machill, G., Barbujani, G., Danieli, G.A., Herrmann, F.H., 1991. Segregation and sporadic cases in families with Hunter’s syndrome. J. Med. Genet., 28(6):398-401.

[14] Rathmann, M., Bunge, S., Beck, M., Kresse, H., Tylki-Szymanska, A., Gal, A., 1996. Mucopolysaccharidosis type II (Hunter syndrome): mutation “hot spots” in the iduronate-2-sulfatase gene. Am. J. Hum. Genet., 59(6):1202-1209.

[15] Xu, X.H., Ye, X.F., Cai, H.W., Guo, Y.B., 2005. The method of assaying urinary GAGs quickly. J. Tropical Med., 5(Suppl.):20-21 (in Chinese).

[16] Zhang, C.Y., Li, L.Y., Liu, S.F., Fu, J.J., Lu, G.X., 2004. Detection of a new mutation (G1253T) of iduronate-2-sulfatase gene for the patient with mucopolysaccharidosis type II. Chin. J. Med. Genet., 21(3):269-271 (in Chinese).